Cargando…
2816. Comparative Effectiveness of Meropenem/Vaborbactam vs. Ceftazidime/Avibactam among Adults Hospitalized with an Infectious Syndrome in the US, 2019-2021
BACKGROUND: Increasing rates of antimicrobial resistance have complicated the treatment of severe infections. Designated an “urgent threat” by the CDC, carbapenem-resistant Enterobacterales (CRE) lead to excess morbidity and mortality in multiple syndromes. Although several novel agents exist with a...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677402/ http://dx.doi.org/10.1093/ofid/ofad500.2427 |